Mike Botta
Contributing Editor

As a Contributing Editor for Advantage Business Media's manufacturing group, Mike Botta contributes across all of the manufacturing brands, creating content and spearheading a variety of projects. Mike has held senior publishing positions at the Fairchild Publications and Chilton Publishing units of Capital Cities/ABC, Reed Business Information, Advantage Business Media (2006-2007), and Thomas Publishing. He served as Editor-in-Chief of the American Metal Market daily business newspaper for several years, eventually moving up to the position of Publisher. He joined Reed in Rockaway, NJ in 2003 as Editorial Director of the manufacturing publications and was later named Publishing Director of the manufacturing group. When Advantage acquired the Rockaway properties in 2006, Mike was named Director of Content. Most recently he served as Editorial Director of TCC Media’s Industrial Equipment News and handled a variety of special projects for other publications, including production of Show Dailies and in-depth interviews with business leaders. Mike and his family relocated from Northern New Jersey to the suburbs of Phoenix, AZ in 2009.

By combining already established drugs in lower doses, PLEOTHERAPY could improve targeted therapy and reduce costs. Rodolphe Hajj of Pharnext answers...
Contributing Editor
|
9.14.2017
12:04pm
Unlike all of the European Union countries where braille is mandatory on pharmaceutical packaging, the U.S. still considers it to be an optional guideline.
Contributing Editor
|
9.14.2017
11:46am
The FDA issued updates on August 11 regarding drugs that are currently in shortage.
Contributing Editor
|
8.11.2017
10:00am
The company reported that 2Q results were lower than anticipated due to the performance of its U.S. generics business and the continued deterioration in...
Contributing Editor
|
8.3.2017
10:43am
As the U.K. faces the Brexit deadline, EU member states have until the end of today to submit bids for the relocation of the European Medicines Agency (EMA)....
Contributing Editor
|
7.31.2017
9:00am
Advertisement
An Oregon man had accused AbbVie Inc. of misleading him and his doctor about the risks of the testosterone booster AndroGel, claiming it led to his heart...
Contributing Editor
|
7.25.2017
10:17am
The FDA issued updates on July 24 regarding drugs that are currently in shortage.
Contributing Editor
|
7.24.2017
9:26am
Division rebrands as UL Compliance to Performance, a service that goes beyond employee learning to full company compliance, safety, and operational strategy.
Contributing Editor
|
7.20.2017
7:50am
The fact that bioinformatics has emerged as a key tool for drug discovery processes due to its high throughput screening, aided by recent advancements in...
Contributing Editor
|
7.19.2017
7:45am
AJ Manufacturing moves to larger facility, adds new equipment and increases capacity by 50 percent. The company specializes in HVAC diffusers, grilles, dampers...
Contributing Editor
|
7.17.2017
5:00am
While the law itself has not changed, it appears the FDA intends to provide some compliance breathing room for those involved in the product identifier...
Contributing Editor
|
6.30.2017
5:05pm
The agency is seeking removal of reformulated Opana ER from the U.S. market saying that the benefits of the drug may no longer outweigh its risks. The company...
Contributing Editor
|
6.9.2017
8:00am
The FDA sent an update on June 5 of the drugs that are currently in shortage.
Contributing Editor
|
6.5.2017
5:38pm
Advertisement
One big concern continues to center around a shortage of manufacturers even as demand increases.
Contributing Editor
|
5.17.2017
8:03am
India-based Dr. Reddy's expects the bulk of short-term market growth to be in complex generics, while mid- to long-term likely will shift toward...
Contributing Editor
|
5.10.2017
1:20pm
Despite immense challenges and hurdles, biosimilars may be where generic medicines were in the mid-1980s.
Contributing Editor
|
5.10.2017
1:15pm
Leveraging tech transfer and analytical capabilities to enter new markets and absorbing additional production steps that brand owners are seeking to offload.
Contributing Editor
|
5.10.2017
1:05pm
The appeal involves a 2016 ruling by the California Supreme Court that found that out-of-state plaintiffs could sue the drug company for injuries even though...
Contributing Editor
|
4.25.2017
9:00am
The FDA sent an update on April 24 of the drugs that are currently in shortage.
Contributing Editor
|
4.24.2017
10:22am
A suburban Chicago woman has been awarded $3 million in a lawsuit against GlaxoSmithKline, the company she blamed for her husband's suicide. In a...
Contributing Editor
|
4.21.2017
10:22am
The FDA sent updates during the period ending April 20 of the drugs that are currently in shortage.
Contributing Editor
|
4.20.2017
10:56am
Advertisement
Eosera unveils Earwax MD, an earwax impaction solution designed to provide relief for the estimated 18 million people in the U.S. alone who seek medical care...
Contributing Editor
|
4.18.2017
4:00am
The FDA said that until all violations are completely corrected and compliance with cGMP is confirmed, the agency may withhold approval of new applications or...
Contributing Editor
|
4.12.2017
11:03am
Finger pointing and controversy in ‘pharmaland’ as the pharmaceutical lobby blames the insurance companies, those who administer drug plans blame the drug...
Contributing Editor
|
4.7.2017
10:00am
The FDA sent updates during the week ending April 7 of the drugs that are currently in shortage.
Contributing Editor
|
4.7.2017
9:15am
The FDA sent updates this week of the drugs that are currently in shortage.
Contributing Editor
|
3.29.2017
10:00am
With the recent acquisition of Finesse Solutions, Inc., Thermo Fisher Scientific now is in a unique position as the only bioproduction supplier that can...
Contributing Editor
|
3.27.2017
9:00am
The move by Great Britain to step away from the European Union may be sending chills of uncertainty to many businesses in the United Kingdom, but to at least...
Contributing Editor
|
3.22.2017
2:00pm
Watson-Marlow Introduces New Peristaltic Pump; Datwyler Debuts Advanced Manufacturing Concept; Optima Pharma Demos MultiUse Filler.
Contributing Editor
|
3.22.2017
10:22am
Top honors go to technology on display from Asahi Kasei Bioprocess; Bio-Rad Laboratories; Nemera; Watson-Marlow Fluid Technology Group; Bausch & Ströebel...
Contributing Editor
|
3.21.2017
10:00am
The FDA sent updates this week of the drugs that are currently in shortage.
Contributing Editor
|
3.16.2017
7:00am
The annual tradeshow, focused on pharmaceutical, biopharmaceutical, biotechnology, and medical device development and manufacturing, is expected to attract...
Contributing Editor
|
3.6.2017
11:25am
U.S. companies, including Pfizer and Johnson & Johnson, in total funded 34 new investment projects, amounting to $642 million — a third of all foreign...
Contributing Editor
|
2.27.2017
7:00am
Merck's EPOCH study of verubecestat for the treatment of mild to moderate Alzheimer’s disease to stop for lack of efficacy. The APECS study in people with...
Contributing Editor
|
2.15.2017
8:09am
The guidance describes FDA's current thinking on the need for biological products licensed under the Public Health Service Act to bear nonproprietary...
Contributing Editor
|
1.13.2017
10:11am
Health care stocks fell yesterday after President-elect Donald Trump said new bidding procedures are needed to stem rising drug costs.
Contributing Editor
|
1.12.2017
10:09am
Researchers in California used CAR-T therapy, a type of immunotherapy, to treat a Seattle man suffering from recurrent multifocal glioblastoma.
Contributing Editor
|
12.29.2016
10:34am
The FDA approved the drug Spinraza, the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive...
Contributing Editor
|
12.27.2016
7:30am
Actelion announced yesterday that it has re-entered talks with Johnson & Johnson regarding a possible 'strategic transaction.'
Contributing Editor
|
12.22.2016
10:30am